You are here: Industry Insights > cipla

News List

Alvotech, Cipla Gulf Ink Biosimilar Deal contractpharma
July 30, 2019
Will partner for the commercialization of key biosimilar in select emerging markets.
Cipla releases financial results for FY19 expressbpd
May 24, 2019
The profit after tax (PAT) for Q4 stood at Rs 367 Cr and for FY19 stood at Rs 1528 Cr
Pulmatrix and Cipla collaborate to develop asthma drug pharmaceutical-technology
April 18, 2019
Pulmatrix and Cipla Technologies have signed a definitive agreement to jointly develop and commercialise Pulmazole to treat allergic bronchopulmonary aspergillosis (ABPA) in asthma patients.
Pulmatrix signs binding agreement with Cipla worth $22M biospectrumasia
April 02, 2019
Pulmatrix enters into binding term sheet with Cipla Technologies LLC for the development and commercialization of Pulmazole
Cipla to launch cinacalcet hydrochloride tablets in US financialexpress
March 06, 2019
Cinacalcet tablets are indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease on dialysis.
Cipla taps Wellthy for digital therapeutics expertise pharmaphorum
February 20, 2019
Indian pharma company Cipla has made another play in the digital medicine category by taking a near-12% stake in start-up Wellthy Therapeutics.
Cipla receives approval for Pfizer’s Depo-Provera biospectrumasia
January 29, 2019
It is a progestin indicated only for the prevention of pregnancy
Bio-Thera Solutions Ltd Partners with Cipla Ltd to Market Key Cancer Biosimilar firstwordpharma
January 15, 2019
BAT-1706 is a mAb biosimilar to Genentech's Avastin® which is currently approved for six indications including metastatic colorectal cancer, recurrent glioblastoma and non-squamous non-small cell lung cancer.
Cipla recalls 4,800 bottles of anti-HIV tablets from American market expressbpd
January 02, 2019
Nevirapine extended-release tablets, 400 mg in the 30-count bottle have been manufactured by Cipla at its Goa facility.
Tedor Appoints Formulation Development Head November 12, 2018
Gupta brings more than 21 years of experience in the pharmaceutical industry

Previous page 1 2 3 4 5 6 7 8 Next page